1. Home
  2. HUDI vs SKYE Comparison

HUDI vs SKYE Comparison

Compare HUDI & SKYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Huadi International Group Co. Ltd.

HUDI

Huadi International Group Co. Ltd.

N/A

Current Price

$0.52

Market Cap

7.6M

Sector

Industrials

ML Signal

N/A

Logo Skye Bioscience Inc.

SKYE

Skye Bioscience Inc.

N/A

Current Price

$0.80

Market Cap

6.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HUDI
SKYE
Founded
1998
2012
Country
China
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.6M
6.4M
IPO Year
2019
2013

Fundamental Metrics

Financial Performance
Metric
HUDI
SKYE
Price
$0.52
$0.80
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
★ $9.00
AVG Volume (30 Days)
49.9K
★ 101.8K
Earning Date
06-29-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.33
$0.26
52 Week High
$1.67
$11.04

Technical Indicators

Market Signals
Indicator
HUDI
SKYE
Relative Strength Index (RSI) 46.45 38.35
Support Level $0.45 $0.50
Resistance Level $0.55 $1.28
Average True Range (ATR) 0.06 0.20
MACD 0.01 0.01
Stochastic Oscillator 51.53 55.23

Price Performance

Historical Comparison
HUDI
SKYE

About HUDI Huadi International Group Co. Ltd.

Huadi International Group Co Ltd is a manufacturer of industrial stainless steel seamless pipes and tubes products. Its products are used in the oil & gas transmission, chemistry engineering, food processing, medical devices, aeronautics and astronautics, boiler, irrigation works construction, automobile and naval architecture, paper mill and mechanical industries. Company generates revenue from Sales of steel piping products. Products are exported to the United States, Mexico, Thailand, Singapore, Argentina, Taiwan, India, the Philippines, UAE and Canada. Geographically, majority revenue is generated from China.

About SKYE Skye Bioscience Inc.

Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.

Share on Social Networks: